TAK

#475
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
17.8650 USD
+0.08%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
17.8550
17.8900
Faixa anual
12.9900
18.8950
Mudança diária
+0.08%
Mudança mensal
-3.01%
Mudança em 6 meses
+25.94%
Mudança anual
+25.94%
Fechamento anterior
17.8500
Abrir
17.8650
Bid
Ask
Mínimo
17.8550
High
17.8900
Volume
506
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 27.8295 B
  • Employee 47 K
  • Founded N/A
  • CEO Christophe WeberChristophe Weber
  • Website www.takeda.com
  • Headquarter Japan
  • FIGI BBG000LF8708
  • Industry Fabricantes de medicamentos - especializados e genéricos

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Notícias